UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials

Blood advances, 2022-01, Vol.6 (1), p.225-227

2022

Volltextzugriff (PDF)

Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients

Haematologica (Roma), 2013-12, Vol.98 (12), p.e155-e157

2013

Volltextzugriff (PDF)

A practical approach for eliciting expert prior beliefs about cancer survival in phase III randomized trial

Journal of clinical epidemiology, 2009-04, Vol.62 (4), p.431-437.e2

2009

Volltextzugriff (PDF)

Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting

Ophthalmologica (Basel), 2016-01, Vol.236 (4), p.207-214

2016

Volltextzugriff (PDF)

P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL‐LIFE DATA FROM VERONE STUDY

HemaSphere, 2023-08, Vol.7 (S3), p.e578244e-n/a

2023

Volltextzugriff (PDF)

Real‐world Experience of Approved Chimeric Antigen Receptor T‐cell Therapies Compared to Clinical Trials Data

HemaSphere, 2023-06, Vol.7 (6), p.e873-n/a

2023

Volltextzugriff (PDF)

Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma

Journal of clinical oncology, 2001-02, Vol.19 (3), p.742-749

2001

Volltextzugriff (PDF)

Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study

Therapeutic advances in gastroenterology, 2018-01, Vol.11, p.1756283X18756260-1756283X18756260

2018

Volltextzugriff (PDF)

Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study

Journal of clinical oncology, 2008-03, Vol.26 (9), p.1496-1503

2008

Volltextzugriff (PDF)

Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial

The Lancet. Haematology, 2019-09, Vol.6 (9), p.e470-e479

2019

Volltextzugriff (PDF)

Single-arm phase 3 designs: An oxymoron?

Contemporary clinical trials, 2024-06, Vol.141, p.107506-107506, Article 107506

2024

Volltextzugriff (PDF)

Dasatinib or High-Dose Imatinib for Chronic-Phase Chronic Myeloid Leukemia Resistant to Imatinib at a Dose of 400 to 600 Milligrams Daily: Two-Year Follow-Up of a Randomized Phase 2 Study (START-R)

Cancer, 2009-09, Vol.115 (18), p.4136-4147

2009

Volltextzugriff (PDF)

Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (21), p.8101-8108

2004

Volltextzugriff (PDF)

Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative Disorders

Journal of clinical oncology, 2001-02, Vol.19 (3), p.772-778

2001

Volltextzugriff (PDF)

Obesity survival paradox in cancer patients: Results from the Physical Frailty in older adult cancer patients (PF-EC) study

Clinical nutrition (Edinburgh, Scotland), 2019-12, Vol.38 (6), p.2806-2812

2019

Volltextzugriff (PDF)

Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials

Contemporary clinical trials communications, 2021-03, Vol.21, p.100709-100709, Article 100709

2021

Volltextzugriff (PDF)

Binet’s Staging System and VH Genes Are Independent but Complementary Prognostic Indicators in Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2003-11, Vol.21 (21), p.3928-3932

2003

Volltextzugriff (PDF)

Outcome of Cancer Patients Considered for Intensive Care Unit Admission: A Hospital-Wide Prospective Study

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4406-4413

2005

Volltextzugriff (PDF)

Toxicity, Progression-Free Survival, and Quality of Life of Patients Treated with Zanubrutinib Versus Ibrutinib: A Q-TWiST Analysis from the ALPINE Study in Relapsed or Refractory Chronic Lymphocytic Leukemia

Blood, 2023-11, Vol.142 (Supplement 1), p.1909-1909

2023

Volltextzugriff (PDF)

Ethnic differences in normal retinal capillary density and foveal avascular zone measurements

International ophthalmology, 2020-11, Vol.40 (11), p.3043-3048

2020

Volltextzugriff (PDF)

Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression

Cancer gene therapy, 2023-07, Vol.30 (7), p.1018-1028

2023

Volltextzugriff (PDF)

26 – 50 von 1.283

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAmerican Journal Of Hematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.120)
Mit Volltextzugriff
(1.104)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.174)
Französisch
(108)
Deutsch
(5)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials

Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients

A practical approach for eliciting expert prior beliefs about cancer survival in phase III randomized trial

Outcomes after a 1-Year Treatment with Ranibizumab for Diabetic Macular Edema in a Clinical Setting

P650: EFFECTIVENESS OF VENETOCLAX ACCORDING TO THE CHARACTERISTICS OF PATIENTS WITH CLL IN MONOTHERAPY AND COMBINATION WITH RITUXIMAB. INTERIM ANALYSIS OF REAL‐LIFE DATA FROM VERONE STUDY

Real‐world Experience of Approved Chimeric Antigen Receptor T‐cell Therapies Compared to Clinical Trials Data

Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma

Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial

Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)

Prognostic Factors for Leukemic Induction Failure in Children With Acute Lymphoblastic Leukemia and Outcome After Salvage Therapy: The FRALLE 93 Study

Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial

Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study

Single-arm phase 3 designs: An oxymoron?

Dasatinib or High-Dose Imatinib for Chronic-Phase Chronic Myeloid Leukemia Resistant to Imatinib at a Dose of 400 to 600 Milligrams Daily: Two-Year Follow-Up of a Randomized Phase 2 Study (START-R)

Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome

Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative Disorders

Obesity survival paradox in cancer patients: Results from the Physical Frailty in older adult cancer patients (PF-EC) study

Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia

Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials

Binet’s Staging System and VH Genes Are Independent but Complementary Prognostic Indicators in Chronic Lymphocytic Leukemia

Outcome of Cancer Patients Considered for Intensive Care Unit Admission: A Hospital-Wide Prospective Study

Toxicity, Progression-Free Survival, and Quality of Life of Patients Treated with Zanubrutinib Versus Ibrutinib: A Q-TWiST Analysis from the ALPINE Study in Relapsed or Refractory Chronic Lymphocytic Leukemia

Ethnic differences in normal retinal capillary density and foveal avascular zone measurements

Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression

Aktive Filter

Suchergebnisse filtern